Europe's Pharma Industry Faces Decline Amid US Policies and China's Biotech Growth

Europe's long-standing dominance in the pharmaceutical sector is reportedly ending, attributed to fragmented capital markets, single-market pricing, uneven reimbursement policies, and the impact of past US policies and China's burgeoning biotech industry.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

cnbcCatalan128d ago

Trump policies, China's biotech boom are ending Europe's pharma powerhouse era

Companies have long lamented Europe's fragmented capital markets, single-market adoption on pricing and clinical trials, and uneven reimbursement policies.

Read full article →

PERSPECTA

PERSPECTA

Europe's Pharma Industry Faces Decline Amid US Policies and China's Biotech Growth

Sources

Trump policies, China's biotech boom are ending Europe's pharma powerhouse era

Related Stories

Hayden Panettiere Dies at 36; Cardiac Arrest Cited, No Trauma Found

West Nile Fever Cases and Fatalities Reported in Serbia and North Macedonia

Metro Manila Inundated by Heavy Monsoon Rains

Hayden Panettiere's Life and Career Remembered Amidst Personal Struggles

PERSPECTA